Be Biopharma

Be Biopharma

Edit info

  • Founded: 2020
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC, RAR, IMM
  • Lead product: Undisclosed
  • Funding: $130M B Apr 2022; $52M A Oct 2020


be.bio

linkedin.com

job board


Drug notes:

Undisclosed RD rare diseases

About:

Be BioPharma is developing Engineered B Cell Medicines (BeCMs). In response to disease, a single B cell produces proteins at rates of thousands per second to maintain health. Be Biopharma has built a three-step platform to modify the B cells to produce therapeutic proteins needed for a specific disease: engineer B cells, expand to secreting plasma cells, and infuse into patients. The modularity of the platform enables them to develop BeCMs for a broad range of diseases. The main goal is to create a new class of highly durable, off-the-shelf, redosable medicines that provide long-lasting production of therapeutic proteins. These will be tested against rare diseases and oncology initially and are in progress towards the clinic.

Jobs:

Be Biopharma
Sr. Scientist, Analytical Development, Process Ana...
Kendall Square, Massachusetts, United States|57 days ago
Apply


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com